RYZUMVI
Total Payments
$44,936
Transactions
479
Doctors
353
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $44,936 | 479 | 353 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $30,992 | 13 | 69.0% |
| Food and Beverage | $13,945 | 466 | 31.0% |
Top Doctors Receiving Payments for RYZUMVI
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , O.D., M.B.A | Optometrist | Lake Oswego, OR | $11,302 | 6 |
| , M.D | Ophthalmology | Columbus, OH | $9,900 | 2 |
| , O.D | Optometrist | Fairfield, CT | $3,474 | 2 |
| , MD | Ophthalmology | Saint Louis, MO | $2,700 | 1 |
| , O.D | Optometrist | Sioux Falls, SD | $1,275 | 1 |
| , O.D | Optometrist | Bowling Green, OH | $1,275 | 1 |
| , O.D | Optometrist | Smyrna, GA | $1,140 | 1 |
| , O.D | Optometrist | Roseville, CA | $207.30 | 2 |
| Alexandra Cleminson | Optometrist | New York, NY | $199.70 | 7 |
| , O.D | Optometrist | Glendale, NY | $176.00 | 6 |
| , O.D | Optometrist | New York, NY | $172.85 | 6 |
| Charles Gold | Optometrist | New York, NY | $147.14 | 6 |
| , O.D | Corneal and Contact Management | New York, NY | $142.75 | 9 |
| , OD | Optometrist | Fresh Meadows, NY | $141.11 | 8 |
| , O.D | Optometrist | Mesa, AZ | $127.27 | 1 |
| , OD | Optometrist | Mesa, AZ | $127.27 | 1 |
| , O.D | Optometrist | Mesa, AZ | $127.27 | 1 |
| , O.D | Optometrist | Chandler, AZ | $127.27 | 1 |
| , O.D | Optometrist | Glendale, AZ | $127.27 | 1 |
| , OD | Optometrist | Scottsdale, AZ | $127.27 | 1 |
| , O.D | Optometrist | Gilbert, AZ | $127.27 | 1 |
| , O.D | Optometrist | Glendale, AZ | $127.27 | 1 |
| , O.D | Optometrist | Avondale, AZ | $127.26 | 1 |
| , O.D | Optometrist | Mesa, AZ | $127.26 | 1 |
| , OD | Optometrist | Scottsdale, AZ | $127.26 | 1 |
Ad
Manufacturing Companies
- Oyster Point Pharma, Inc. $44,936
Product Information
- Type Drug
- Total Payments $44,936
- Total Doctors 353
- Transactions 479
About RYZUMVI
RYZUMVI is a drug associated with $44,936 in payments to 353 healthcare providers, recorded across 479 transactions in the CMS Open Payments database. The primary manufacturer is Oyster Point Pharma, Inc..
Payment data is available from 2024 to 2024. In 2024, $44,936 was paid across 479 transactions to 353 doctors.
The most common payment nature for RYZUMVI is "Consulting Fee" ($30,992, 69.0% of total).